News and Announcements
News and Announcements
Red Cross Cell and Gene Therapy Starting Materials Now Available on Scientist.com
We’re excited to announce that Red Cross Cell and Gene Therapy Solutions can now be accessed through Scientist.com. This new channel makes it even easier for research teams to explore and request our specialized products. Explore our full range of allogeneic source materials, trusted by organizations advancing breakthrough cell and gene therapies, on Scientist.com and our product webpages.
Prepare Your LIS for New Platelet Product Codes
Following the successful implementation of the dual split process, the Red Cross now produces four platelet products from a single high-yield donation, and enhancement from the previous standard of three. All Fourth container products are fully licensed and all customers should be prepared to receive the products, including platelet units with and additional 4th container product code. Please take action now by updating your Laboratory Information System (LIS) with the new product codes listed in the linked table.
A full list of product codes is available in the Hospital Partner Resource Guide (HPRG).
INTERCEPT® Fibrinogen Complex (IFC) A vital addition to your inventory for treating fibrinogen deficiency, offering consistent quality, extended shelf life, and improved logistics. Scheduled orders recommended, ad hoc ordering available.
Learn more >>
Order Now >>
Educational Resources
Upcoming Events
-
Supporting the Blood Needs of Patients with Sickle Cell Disease
September 3, 2026
-
Empower Group O: Optimizing O Negative RBC Utilization Using a Data-Driven Approach
September 17, 2026
Speaker:Mrigender Singh Virk, MD
Stanford University
PLUS Online
-
Clinical Significance of Anti-M in Pregnancy and Self-Reported Ancestry
Despite being the first antigen discovered in the MNS blood group system, M and the expression of its corresponding antibody remain enigmatic. Anti-M can be naturally occurring in an M-negative pregnant woman even when her fetus is M-negative. The Blood Group Antigen FactsBook notes that anti-M hemolytic disease of the fetus and newborn (HDFN) is […]
The post Clinical Significance of Anti-M in Pregnancy and Self-Reported Ancestry appeared first on Red Cross Plus Online Blog.
-
Prehospital Whole Blood vs. Blood Components for Trauma
On May 18, 2026, the New England Journal of Medicine published the results of a multicenter study in adult patients with trauma and signs of hemorrhage, comparing prehospital transfusion with group O whole blood (WB) to transfusion with blood components (packed red cells, plasma, or both). WB was screened for anti-A and anti-B titers less […]
The post Prehospital Whole Blood vs. Blood Components for Trauma appeared first on Red Cross Plus Online Blog.
-
Bringing Blood Closer to the Moment of Need: How Prehospital Transfusion Is Shaping Trauma Care
In trauma care, minutes matter. For patients experiencing life-threatening hemorrhage, the time between injury and hospital arrival can be critical. While emergency medical responders are highly trained to stabilize patients in the field, access to blood products before arrival at the hospital remains limited in many parts of the country. Prehospital transfusion programs are helping change that […]
The post Bringing Blood Closer to the Moment of Need: How Prehospital Transfusion Is Shaping Trauma Care appeared first on Red Cross Plus Online Blog.
Media Messaging Toolkit
The American Red Cross welcomes participation of our hospital partners in the recruitment of blood donors, especially in times of critical shortages. For your convenience, we have made available prepared messaging and graphics that can be used to promote the need for blood donations.